Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) closed at $23.26 in the last session, up 1.09% from day before closing price of $23.01. In other words, the price has increased by $1.09 from its previous closing price. On the day, 0.99 million shares were traded. CNTA stock price reached its highest trading level at $23.48 during the session, while it also had its lowest trading level at $22.5229.
Ratios:
We take a closer look at CNTA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.12 and its Current Ratio is at 10.12. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Wells Fargo on September 03, 2025, initiated with a Overweight rating and assigned the stock a target price of $31.
On July 21, 2025, Truist started tracking the stock assigning a Buy rating and target price of $30.Truist initiated its Buy rating on July 21, 2025, with a $30 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 24 ’25 when Bush Tia L sold 35,000 shares for $24.00 per share. The transaction valued at 840,000 led to the insider holds 121,503 shares of the business.
Bush Tia L bought 35,000 shares of CNTA for $840,000 on Sep 24 ’25. On Sep 16 ’25, another insider, Accardi Mario Alberto, who serves as the President, Orexin Program of the company, sold 8,172 shares for $21.40 each. As a result, the insider received 174,846 and left with 197,394 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 3118548224 and an Enterprise Value of 2985965056. For the stock, the TTM Price-to-Sale (P/S) ratio is 206.82 while its Price-to-Book (P/B) ratio in mrq is 9.03. Its current Enterprise Value per Revenue stands at 199.064 whereas that against EBITDA is -14.488.
Stock Price History:
The Beta on a monthly basis for CNTA is 1.52, which has changed by 0.4546591 over the last 52 weeks, in comparison to a change of 0.1529237 over the same period for the S&P500. Over the past 52 weeks, CNTA has reached a high of $24.13, while it has fallen to a 52-week low of $9.60. The 50-Day Moving Average of the stock is 26.99%, while the 200-Day Moving Average is calculated to be 48.66%.
Shares Statistics:
According to the various share statistics, CNTA traded on average about 1.17M shares per day over the past 3-months and 936110 shares per day over the past 10 days. A total of 133.91M shares are outstanding, with a floating share count of 85.14M. Insiders hold about 36.42% of the company’s shares, while institutions hold 56.11% stake in the company. Shares short for CNTA as of 1757894400 were 5512433 with a Short Ratio of 4.71, compared to 1755216000 on 4645019. Therefore, it implies a Short% of Shares Outstanding of 5512433 and a Short% of Float of 4.84.
Earnings Estimates
The firm’s stock currently is rated by 6.0 analysts. The consensus estimate for the next quarter is -$0.41, with high estimates of -$0.38 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$1.33 and -$1.46 for the fiscal current year, implying an average EPS of -$1.39. EPS for the following year is -$1.67, with 8.0 analysts recommending between -$1.37 and -$2.03.
